|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
33,202,000 |
Market
Cap: |
N/A |
Last
Volume: |
655,586 |
Avg
Vol: |
293,782 |
52
Week Range: |
$31.02 - $31.02 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Bonadio Tom |
Director |
|
2013-03-11 |
4 |
OE |
$13.51 |
$262,256 |
D/D |
19,412 |
56,852 |
|
- |
|
Bonadio Tom |
Director |
|
2013-03-08 |
4 |
AS |
$23.00 |
$210,312 |
D/D |
(9,144) |
37,440 |
|
- |
|
Bonadio Tom |
Director |
|
2013-03-08 |
4 |
OE |
$13.51 |
$123,535 |
D/D |
9,144 |
46,584 |
|
- |
|
Bonadio Tom |
Director |
|
2013-03-05 |
4 |
AS |
$23.00 |
$13,800 |
D/D |
(600) |
37,440 |
|
- |
|
Bonadio Tom |
Director |
|
2013-03-05 |
4 |
OE |
$13.51 |
$8,106 |
D/D |
600 |
38,040 |
|
- |
|
Yu Edward |
VP Reg, Clin & Med Affairs |
|
2013-02-28 |
4 |
D |
$22.33 |
$10,227 |
D/D |
(458) |
18,092 |
|
- |
|
Ozdil Feridun |
EVP of R & D |
|
2013-02-28 |
4 |
D |
$22.33 |
$20,477 |
D/D |
(917) |
13,567 |
|
- |
|
Lichtwardt Gregory |
Executive Vice President, CFO |
|
2013-02-28 |
4 |
D |
$22.33 |
$25,590 |
D/D |
(1,146) |
56,037 |
|
- |
|
Brooks Julie |
EVP, General Counsel |
|
2013-02-28 |
4 |
D |
$22.33 |
$25,590 |
D/D |
(1,146) |
28,816 |
|
- |
|
Yu Edward |
VP Reg, Clin & Med AffairsOffi |
|
2013-02-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
18,550 |
|
- |
|
Lichtwardt Gregory |
Executive Vice President, CFO |
|
2013-02-25 |
4 |
D |
$21.44 |
$13,743 |
D/D |
(641) |
57,183 |
|
- |
|
Bonadio Tom |
Director |
|
2013-02-13 |
4 |
AS |
$23.00 |
$53,912 |
D/D |
(2,344) |
37,440 |
|
- |
|
Bonadio Tom |
Director |
|
2013-02-13 |
4 |
OE |
$13.51 |
$31,667 |
D/D |
2,344 |
39,784 |
|
- |
|
Bonadio Tom |
Director |
|
2013-02-12 |
4 |
AS |
$23.00 |
$195,500 |
D/D |
(8,500) |
37,440 |
|
- |
|
Bonadio Tom |
Director |
|
2013-02-12 |
4 |
OE |
$13.51 |
$114,835 |
D/D |
8,500 |
45,940 |
|
- |
|
Chung David |
Chief Commercial Officer |
|
2013-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
9,800 |
49,800 |
|
- |
|
Brooks Julie |
EVP, General Counsel |
|
2013-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
11,200 |
29,962 |
|
- |
|
Ciano Lori |
Executive Vice President, HR |
|
2013-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
12,600 |
13,149 |
|
- |
|
Ozdil Feridun |
EVP of R & D |
|
2013-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
11,200 |
14,484 |
|
- |
|
Grossman D Keith |
President & CEO |
|
2013-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
70,000 |
204,882 |
|
- |
|
Lichtwardt Gregory |
Executive Vice President, CFO |
|
2013-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
12,600 |
57,824 |
|
- |
|
Tunstall Kathryn |
Chairman of the Board |
|
2013-02-04 |
4 |
AS |
$21.35 |
$288,620 |
D/D |
(13,520) |
165,803 |
|
- |
|
Sharpe Joseph |
Executive VP of Operations |
|
2013-01-22 |
4 |
A |
$0.00 |
$0 |
D/D |
25,200 |
25,200 |
|
- |
|
Ozdil Feridun |
EVP of R & D |
|
2012-12-19 |
4 |
AS |
$22.05 |
$69,524 |
D/D |
(3,153) |
2,513 |
|
- |
|
Ozdil Feridun |
EVP of R & D |
|
2012-12-18 |
4 |
D |
$22.17 |
$151,798 |
D/D |
(6,847) |
5,666 |
|
- |
|
264 Records found
|
|
Page 2 of 11 |
|
|